Metabolic Health
Marine Compound Enterocin Lowers Cholesterol by Targeting Liver Protein ASGR1
Natural polyketide from marine bacteria enhances cholesterol removal and improves fat metabolism in liver cells and mice.
Research Paper
Mar 29, 2026 2
Results for "Fisetin" in Diabetes
20 articles
Metabolic Health
SGLT2 Inhibitor Dapagliflozin Reshapes Metabolism Beyond Blood Sugar Control
New study reveals how the diabetes drug dapagliflozin dramatically alters fat metabolism and kidney function through previously unknown pathways.
Research Paper
Apr 9, 2026 0
Metabolic Health
Finerenone Slows Kidney Decline in Non-Diabetic CKD Patients
A landmark RCT shows finerenone reduces eGFR decline and kidney-cardiovascular events in CKD patients without diabetes.
Research Paper
Jun 8, 2026 0
Metabolic Health
New Injectable Drug Cuts Cholesterol 28% in Teens With Genetic High Cholesterol
Inclisiran safely reduced LDL cholesterol by 28% in adolescents with familial hypercholesterolemia, offering hope for early intervention.
Research Paper
Mar 29, 2026 0
Metabolic Health
New Protein Target Could Unlock FGF21's Power Against Fatty Liver Disease
Scientists discover how FGF21 fights liver disease through a key protein, opening new treatment paths for metabolic dysfunction.
Research Paper
Apr 3, 2026 0
Metabolic Health
Tirzepatide Cuts Key Inflammation Markers by Up to 34% in Meta-Analysis
A systematic review of 8 studies finds tirzepatide significantly reduces hsCRP and IL-6 across all doses and populations.
Research Paper
May 30, 2026 0
Metabolic Health
Melatonin Reverses Metabolic Damage in IVF Children by Fixing Liver Enzymes
New research shows melatonin supplementation during IVF can prevent obesity and glucose problems in offspring by restoring liver function.
Research Paper
Apr 9, 2026 0
Metabolic Health
Nanoplastics Accumulate in Mouse Testes and Trigger Sperm-Killing Ferroptosis via CISD1
50 nm polystyrene nanoplastics accumulate in mouse testes, degrading sperm quality and triggering iron-dependent cell death through a newly identified mitochondrial pathway.
Research Paper
Jun 20, 2026 0
Metabolic Health
New PKU Drug Sepiapterin Shows 70% Better Results Than Current Standard Treatment
Breakthrough study reveals sepiapterin dramatically outperforms existing PKU therapy, offering hope for better metabolic control.
Research Paper
Mar 29, 2026 3
Metabolic Health
Inclisiran Shows Promise for Treating High Cholesterol in Children
New research examines whether the cholesterol-lowering drug inclisiran could benefit pediatric patients with genetic high cholesterol.
Research Paper
Mar 29, 2026 0
Metabolic Health
Phosphatidylserine Supplement Improves Liver Health and Blood Sugar Control in Mice
New research shows phosphatidylserine supplementation reduces liver fat and inflammation while improving glucose control through enhanced fat metabolism.
Research Paper
Mar 29, 2026 3
Metabolic Health
New Dual-Target Drug Amycretin Achieves 24% Weight Loss in Clinical Trials
Novel obesity drug targeting two pathways simultaneously shows unprecedented weight loss results in recent clinical studies.
Research Paper
Mar 28, 2026 1
Metabolic Health
Single Molecule Activates Five Receptors to Target Obesity and Metabolic Disease
A novel conjugate merges GLP-1/GIP incretin signaling with pan-PPAR activation in one molecule, potentially revolutionizing metabolic therapy.
Research Paper
May 9, 2026 0
Metabolic Health
Semaglutide protects liver through direct action on blood vessel cells, not weight loss
New research reveals semaglutide's liver benefits work independently of weight loss through specialized liver blood vessel cells.
Research Paper
Apr 16, 2026 0
Metabolic Health
GLP-1 Drugs Show Liver Benefits in Fatty Liver Disease Beyond Weight Loss
Updated review of anti-obesity medications in MASLD finds GLP-1 agonists reduce steatosis and fibrosis, while newer dual/triple agonists show even greater metabolic promise.
Research Paper
Jun 4, 2026 0
Metabolic Health
Tirzepatide Cuts Cardiovascular Risk More Than Semaglutide in Sleep Apnea Patients
A real-world study of 15,000+ patients finds tirzepatide outperforms both semaglutide and liraglutide in preventing major cardiac events.
Research Paper
Jun 4, 2026 0
Metabolic Health
Tirzepatide Shows Remarkable Weight Loss Results in Japanese Adults with Obesity
Weekly tirzepatide injections led to up to 22% weight loss in Japanese participants, with 96-100% achieving clinically significant results.
Research Paper
Mar 29, 2026 1
Metabolic Health
More Powerful GLP-1 Drugs Don't Mean More Side Effects, Major Analysis Finds
A systematic review of 38 trials finds tirzepatide cuts HbA1c nearly 3x more than lixisenatide with similar GI side effect rates.
Research Paper
Jun 4, 2026 0
Metabolic Health
Propionate Protects Diabetic Liver from High-Fat Diet Damage in New Study
Sodium propionate reduced liver inflammation and fat accumulation in diabetic mice fed high-fat, AGE-rich diets through multiple protective mechanisms.
Research Paper
Apr 9, 2026 0
Metabolic Health
MASH Treatment Revolution: Semaglutide, Tirzepatide Lead a New Drug Era
A landmark JCI review maps the expanding pharmacological arsenal for MASH, from GLP-1 agonists to triple receptor therapies and precision medicine.
Research Paper
May 30, 2026 0
Page 1 of 2Next